De Pità O - Search Results

1

Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.

Amerio P, Frezzolini A, Abeni D, Teofoli P, Girardelli CR, De Pità O, Puddu P. Amerio P, et al. Among authors: de pita o. Clin Exp Rheumatol. 2002 Jul-Aug;20(4):535-8. Clin Exp Rheumatol. 2002. PMID: 12175109

2

Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.

Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, De Pità O, Puddu P, Paganelli R, Russo G. Scala E, et al. Among authors: de pita o. Clin Exp Immunol. 2004 Dec;138(3):540-6. doi: 10.1111/j.1365-2249.2004.02642.x. Clin Exp Immunol. 2004. PMID: 15544634 Free PMC article.

3

Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.

Frezzolini A, Teofoli P, Cianchini G, Barduagni S, Ruffelli M, Ferranti G, Puddu P, De Pita O. Frezzolini A, et al. Among authors: de pita o. Eur J Dermatol. 2002 Jan-Feb;12(1):27-31. Eur J Dermatol. 2002. PMID: 11809592

4

Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.

Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pità O, Puddu P. Amerio P, et al. Among authors: de pita o. Curr Drug Targets Inflamm Allergy. 2003 Mar;2(1):81-94. doi: 10.2174/1568010033344480. Curr Drug Targets Inflamm Allergy. 2003. PMID: 14561178 Review.

5

Intravenous immunoglobulin therapy: modification of the immunofluorescence pattern in the skin of six patients with systemic lupus erythematosus.

Puddu P, De Pità O, Ruffelli M, Bellucci AM, Girardelli CR, Galeazzi M, Marcolongo R. Puddu P, et al. Among authors: de pita o. Arthritis Rheum. 1996 Apr;39(4):704-5. doi: 10.1002/art.1780390426. Arthritis Rheum. 1996. PMID: 8630125 No abstract available.

6

Schnitzler's syndrome: report of a new case and a review of the literature.

Puddu P, Cianchini G, Girardelli CR, Colonna L, Gatti S, de Pita O. Puddu P, et al. Among authors: de pita o. Clin Exp Rheumatol. 1997 Jan-Feb;15(1):91-5. Clin Exp Rheumatol. 1997. PMID: 9093781 Review.

7

T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30).

De Pitá O, Frezzolini A, Cianchini G, Ruffelli M, Teofoli P, Puddu P. De Pitá O, et al. Arch Dermatol Res. 1997 Nov;289(12):667-70. doi: 10.1007/s004030050259. Arch Dermatol Res. 1997. PMID: 9452886

8

Squamous cell carcinoma-related antigen (SCCr-Ag), sICAM-1 and beta 2-microglobulin are useful markers of disease activity in psoriasis.

De Pità O, Frezzolini A, Cianetti A, De Sanctis G, Fontana L, Bottari V. De Pità O, et al. Among authors: de sanctis g. Acta Derm Venereol. 1999 Mar;79(2):132-5. doi: 10.1080/000155599750011354. Acta Derm Venereol. 1999. PMID: 10228632 Free article.

9

The role of proopiomelanocortin-derived peptides in skin fibroblast and mast cell functions.

Teofoli P, Frezzolini A, Puddu P, De Pità O, Mauviel A, Lotti T. Teofoli P, et al. Among authors: de pita o. Ann N Y Acad Sci. 1999 Oct 20;885:268-76. doi: 10.1111/j.1749-6632.1999.tb08684.x. Ann N Y Acad Sci. 1999. PMID: 10816660

10

Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity.

Frezzolini A, Paradisi M, Zaffiro A, Provini A, Cadoni S, Ruffelli M, De Pità O. Frezzolini A, et al. Among authors: de pita o. Allergy. 2002 Sep;57(9):815-20. doi: 10.1034/j.1398-9995.2002.23687.x. Allergy. 2002. PMID: 12169178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters